Insight

Oncotype DX Colon Recurrence Score in stage II colon cancer, summary by Erman Akkus

Photo from Erman Akkus/X

Aug 17, 2024, 19:56

Oncotype DX Colon Recurrence Score in stage II colon cancer, summary by Erman Akkus

Erman Akkus, Medical Oncology Fellow a post on X:

“Oncotype DX Colon Recurrence Score in stage II colon cancer at ESMO Open.

Real-word data, 938 patients
Higher score ->worse clinicopathologial factors, higher treatment
Score is prognostic
In high score (41-100), ChT vs observation, colon cancer specific survival, p=0.035“

Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data

Authors: B. Brenner, K. Shulman, A. Hubert, S. Man, R. Geva, I. Ben-Aharon, S. Fennig, M. Mishaeli, N. Yarom, G. Bar-Sela, R. Brenner, A. Shai, F.L. Baehner, C. Russell, L. Soussan-Gutman ,H. Voet, A. Bareket-Samish, and N. Liebermann.

Oncotype DX Colon Recurrence Score in stage II colon cancer, summary by Erman Akkus

Source: Erman Akkus/X

A. Bareket-Samish A. Hubert Ankara Üniversitesi Tıp Fakültesi B. Brenner cancer Colon cancer Erman Akkus ESMO Open H. Voet K. Shulman N. Liebermann OncoDaily Oncology

King Charles III Hospitalized Following Side Effects from Cancer Treatment

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

Miranda McKeon: Battling Breast Cancer at 19, Inspiring Millions on Instagram

WHO Takes a Creative Leap in Raising Awareness for Colorectal Cancer